ft 09 nov 93 uk compani news swiss get celltech stake celltech bio technolog compani issu pathfind prospectu yesterday plan reserv fifth share sale switzerland slough base compani leader genet engin antibodi contract manufactur seri monoclon antibodi roch swiss drug group flotat rais pound 30m pound 35m compani exist drug develop programm valu celltech pound 180m share price novemb 25 offer close decemb 2 administr british amp commonwealth current hold 36 per cent share end less 10 per cent stake sell flotat